Waldencast Reports Q1 2025 Financial Results Amid Challenges

Waldencast Acquisition ( (WALD) ) has provided an update.

On May 13, 2025, Waldencast plc announced its financial results for the first quarter of 2025, ending March 31. The company reported a gross profit of $47.2 million, with Milk Makeup and Obagi Medical contributing $20.4 million and $26.9 million, respectively. Despite these figures, Waldencast faced a net loss of $20.7 million. The announcement highlights the company’s strategic focus on expanding its beauty and wellness platform, although it faces challenges such as material weaknesses in financial reporting and ongoing investigations.

The most recent analyst rating on (WALD) stock is a Hold with a $4.30 price target. To see the full list of analyst forecasts on Waldencast Acquisition stock, see the WALD Stock Forecast page.

Spark’s Take on WALD Stock

According to Spark, TipRanks’ AI Analyst, WALD is a Neutral.

Waldencast Acquisition’s overall score is driven by strong revenue growth and positive sentiment from recent earnings, but is tempered by challenges in achieving profitability and cash generation. Technical indicators show moderate market momentum, but valuation concerns remain due to unprofitability. Strategic initiatives in innovation and expansion provide a positive outlook, although regulatory costs and inventory adjustments pose risks.

To see Spark’s full report on WALD stock, click here.

More about Waldencast Acquisition

Waldencast plc operates in the beauty and wellness industry, focusing on building a multi-brand platform by creating, acquiring, and scaling high-growth, purpose-driven brands. The company is involved in various categories including skin, color, hair, body, wellness, and fragrance, and operates across multiple geographies and channels.

Average Trading Volume: 51,897

Technical Sentiment Signal: Sell

Current Market Cap: $378M

See more data about WALD stock on TipRanks’ Stock Analysis page.